朝雲集團(06601.HK)以包括注資方式收購中博綠亞30%股權
朝雲集團(06601.HK)公布,附屬「廣州朝雲」擬向中博綠亞的實際控制人劉高升收購中博綠亞23.45%的股權。同時,廣州朝雲亦通過注資的方式收購中博綠亞8.5625%的股權。於投資完成後,中博綠亞將由廣州朝雲擁有30.0046%,而廣州朝雲將成為中博綠亞的第二大股東,並於未來可能收購中博綠亞的股權時擁有優先購買權。
另外,廣州朝雲與中博綠亞決定在寵物保健品和寵物藥品行業的研發資源共享、產品開發、供應鏈合作、資本合作等方面建立戰略合作夥伴關係。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.